Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00428246 · ClinicalTrials.gov registry record · NA
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00428246 is a NA study that has completed, run by Indiana University. The registered enrollment target is 24 participants.
The verdict
NCT00428246, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The study is about possible protective effects of paricalcitol (Zemplar) upon inflammation, blood pressure and kidney function. Kidney Inflammation occurs when white blood cells become abnormally stimulated and accumulate in the kidney and cause damage to the kidney. The purpose of this study is to determine if paricalcitol helps improve kidney injury, blood pressure control and kidney function in patients with chronic kidney disease. The study will last about 7 weeks and involves about 8 visits to the medical center.
Interventions
- DRUG Placebo
- DRUG paricalcitol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00428246
The ClinicalTrials.gov registry entry for NCT00428246 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00428246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00428246 about?
NCT00428246 is a clinical study titled "Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation". The study is about possible protective effects of paricalcitol (Zemplar) upon inflammation, blood pressure and kidney function. Kidney Inflammation occurs when white blood cells become abnormally stimulated and accumulate in the kidney and cause damage to the kidney. The purpose of this study is to ...
What is the current status of trial NCT00428246?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2006-11. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00428246?
The interventions under investigation include: Placebo (DRUG), paricalcitol (DRUG).
Who is sponsoring clinical trial NCT00428246?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.